Zobrazeno 1 - 10
of 65
pro vyhledávání: '"N Neymark"'
Publikováno v:
European Journal of Ophthalmology. 18:52-59
Purpose This study describes the treatment in ordinary clinical practice in Spain of patients with glaucoma with a two-drug combination therapy. The authors present the treatment outcome as end-of-period intraocular pressure (IOP) and the calculated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3199ed425c5c3971974fa9bb956afea5
https://doi.org/10.1177/112067210801800109
https://doi.org/10.1177/112067210801800109
Autor:
I Adriaenssen, N Neymark
Publikováno v:
European Journal of Cancer. 35:1789-1795
With the aim of estimating and comparing the direct hospital costs of managing patients with advanced colorectal cancer in various countries, data on resource utilisation and unit prices were collected. Data on the consumption of medical resources we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c121e1850614da349ceec41933a30b
https://doi.org/10.1016/s0959-8049(99)00216-6
https://doi.org/10.1016/s0959-8049(99)00216-6
Autor:
Sally P. Stenning, Laurence Collette, Stan B. Kaye, E. Lallemand, N. Neymark, P.H.M. de Mulder, R. de Wit, Richard Sylvester, Graham M. Mead, Sophie D. Fosså
Publikováno v:
Journal of the National Cancer Institute, 91(10), 839-846. Oxford University Press
Background: Because metastatic nonseminomatous germ cell cancer is a rare but treatable cancer, we have explored whether there is an association between the experience of the treating institution with this disease and the long-term clinical outcome o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae5ce477cb1cfe66ec60689e79426472
https://doi.org/10.1093/jnci/91.10.839
https://doi.org/10.1093/jnci/91.10.839
Autor:
N. Neymark
Publikováno v:
Annals of Oncology. 9:1167-1172
This certainly does not mean that the exact type ofevidence to take into consideration is indisputable.Thus, Maynard [2] recently accused leading spokesmenfor the evidence based medicine 'movement' of com-pletely ignoring treatment costs by recommend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91b951e96ea7dd380761ca30c682a076
https://doi.org/10.1023/a:1008450824325
https://doi.org/10.1023/a:1008450824325
Autor:
D A Revicki, Richard D. Gelber, Linda Davies, Gordon H. Guyatt, David Osoba, B.E. Hillner, K Torfs, Kevin A. Schulman, K Simpson, N Neymark, D. Machin, Erik Nord, W Kiebert, Paul Kind, Peter Fayers
Publikováno v:
European Journal of Cancer. 34:1317-1333
In recent years, quality of life (QoL) and economic evaluations have become increasingly important as additional outcome measures in cancer clinical trials. However, both fields of research are relatively new and in need of finding solutions to a sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0484344606154b56e75f072b4cde9908
https://doi.org/10.1016/s0959-8049(98)00074-4
https://doi.org/10.1016/s0959-8049(98)00074-4
Autor:
N. Neymark
Publikováno v:
Annals of Oncology. 11:1513-1515
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaa818ab097452407f50bc999e86b707
https://doi.org/10.1023/a:1008379628096
https://doi.org/10.1023/a:1008379628096
Publikováno v:
European journal of cancer (Oxford, England : 1990). 37(14)
We present a retrospective cost-effectiveness analysis using data from a randomised controlled trial (EORTC 22863) of the addition of early hormonal therapy with a luteinising hormone-releasing hormone (LHRH) analogue to radiotherapy in the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::49a18cb4d61b89cc87178859f0800456
https://pubmed.ncbi.nlm.nih.gov/11549430
https://pubmed.ncbi.nlm.nih.gov/11549430
Autor:
N, Neymark, G, Rosti
Publikováno v:
Haematologica. 85(7)
It is increasingly being realized that there are very considerable variations in individual hospitals' strategies for managing a particular group of patients, even if using similar therapeutic regimens. Such variations make it impossible to generaliz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::77567d739db00781441ce192e583e58a
https://pubmed.ncbi.nlm.nih.gov/10897126
https://pubmed.ncbi.nlm.nih.gov/10897126
Autor:
N, Neymark
Publikováno v:
Acta oto-rhino-laryngologica Belgica. 53(3)
This article first discusses at what level of clinical decision making cost considerations may be most pertinent and important. It is argued that cost assessments will be of most relevance and value at an intermediate level of clinical decision makin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9068822e6920692a7e2f69606fd5986d
https://pubmed.ncbi.nlm.nih.gov/10635410
https://pubmed.ncbi.nlm.nih.gov/10635410
Autor:
L, Collette, R J, Sylvester, S P, Stenning, S D, Fossa, G M, Mead, R, de Wit, P H, de Mulder, N, Neymark, E, Lallemand, S B, Kaye
Publikováno v:
Journal of the National Cancer Institute. 91(10)
Because metastatic nonseminomatous germ cell cancer is a rare but treatable cancer, we have explored whether there is an association between the experience of the treating institution with this disease and the long-term clinical outcome of the patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ebd8efd5511e752d308dcd2242d5fa4f
https://pubmed.ncbi.nlm.nih.gov/10340895
https://pubmed.ncbi.nlm.nih.gov/10340895